Financial results - NEURODERMAMED SRL

Financial Summary - Neurodermamed Srl
Unique identification code: 35877484
Registration number: J04/456/2016
Nace: 8622
Sales - Ron
11.208
Net Profit - Ron
8.682
Employees
Open Account
Company Neurodermamed Srl with Fiscal Code 35877484 recorded a turnover of 2024 of 11.208, with a net profit of 8.682 and having an average number of employees of - . The company operates in the field of Activităţi de asistenţă medicală specializată having the NACE code 8622.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Neurodermamed Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR - 737 2.078 2.580 5.233 7.727 7.961 8.758 14.247 11.208
Total Income - EUR - 737 2.078 2.580 5.233 7.727 7.961 8.758 35.037 11.208
Total Expenses - EUR - 667 1.348 620 193 194 398 314 21.526 1.100
Gross Profit/Loss - EUR - 70 730 1.961 5.040 7.533 7.563 8.444 13.512 10.107
Net Profit/Loss - EUR - 48 668 1.883 4.883 7.350 7.369 8.236 11.916 8.682
Employees - 0 0 0 0 0 0 0 0 0
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales decreased by -20.9%, from 14.247 euro in the year 2023, to 11.208 euro in 2024. The Net Profit decreased by -3.167 euro, from 11.916 euro in 2023, to 8.682 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Neurodermamed Srl

Rating financiar

Financial Rating -
NEURODERMAMED SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Neurodermamed Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Neurodermamed Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Neurodermamed Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Neurodermamed Srl - CUI 35877484

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets - 69 0 0 0 0 0 0 0 0
Current Assets - 699 2.520 4.822 9.660 16.913 24.093 12.225 39.848 53.079
Inventories - 0 0 0 0 0 0 0 20.790 25.150
Receivables - 0 0 0 0 0 0 6.550 320 213
Cash - 699 2.520 4.822 9.660 16.913 24.093 5.674 18.737 27.716
Shareholders Funds - 92 759 2.628 7.461 14.669 21.713 8.285 14.578 23.179
Social Capital - 45 44 43 42 41 40 41 40 40
Debts - 676 1.761 2.194 2.199 2.244 2.379 3.940 25.270 29.900
Income in Advance - 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "8622 - 8622"
CAEN Financial Year 8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 53.079 euro in 2024 which includes Inventories of 25.150 euro, Receivables of 213 euro and cash availability of 27.716 euro.
The company's Equity was valued at 23.179 euro, while total Liabilities amounted to 29.900 euro. Equity increased by 8.682 euro, from 14.578 euro in 2023, to 23.179 in 2024.

Risk Reports Prices

Reviews - Neurodermamed Srl

Comments - Neurodermamed Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.